BridgeMD
New treatment option for Loneliness
Official title Need to be Needed (N2BN) Intervention
ClinicalTrials.gov ID: NCT06510439
What this study is testing
- What it's testing
- The proposed study is a randomized, controlled trial (RCT) that will examine the effectiveness of an intervention designed to reduce social isolation and loneliness of adults with serious mental illness (SMI). The intervention will focus on improving their sense of mattering by using acts of kindness and experiencing gratitude through volunteering.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 99
You may be able to join if
- A research diagnosis of Major Depression, Bipolar I, II, or Schizophrenia Spectrum disorder. Participants will be screened by research staff using...
- Ages 18 years old and older
- Living in the community
- Able to communicate in written and oral English
- UCLA-Loneliness Scale score of 6 or higher
You likely can't join if
- Having a legal guardian
- Unable to give informed consent.
- Living situation which restricts their ability to move freely Potential participants failing to meet screening criteria will be informed at the time...
The study team makes the final eligibility decision.
Where it's taking place
- Philadelphia, Pennsylvania, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 99 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Philadelphia, Pennsylvania, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.